Neuvoprerana Foundation - Company Profile

It is a healthcare private not for profit company based in Nashik, Maharashtra, India, established in 2020.
2020 Nashik, Maharashtra, India Active
Last Updated:
Access Report
About Neuvoprerana Foundation

Neuvoprerana Foundation, a active private not for profit company, was established on 15 September 2020 in Nashik, Maharashtra, India. Engaging in human health activities within the healthcare sector, it holds CIN: U85100MH2020NPL346072. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Nilesh Pandit Mahajan (Director), Pandit Punjaram Mahajan (Director), Sanjana Tushar Mahajan (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Fl03 Nishigandh Apt Satpur, Nashik, Maharashtra, 422007.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100MH2020NPL346072

  • Registration Number

    346072

  • Incorporation Date

    15 September 2020

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Neuvoprerana Foundation

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Neuvoprerana Foundation — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Neuvoprerana Foundation?
Current Directors
Name Designation Appointment Date Status
Nilesh Pandit Mahajan Director 15 Sep 2020 Current
Pandit Punjaram Mahajan Director 15 Sep 2020 Current
Sanjana Tushar Mahajan Director 15 Sep 2020 Current
Tushar Pandit Mahajan Director 15 Sep 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Neuvoprerana Foundation.

Enhance accessibility to Neuvoprerana Foundation's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Neuvoprerana Foundation revenue growth over time
Neuvoprerana Foundation profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Neuvoprerana Foundation?

Unlock access to Neuvoprerana Foundation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Neuvoprerana Foundation?

Neuvoprerana Foundation has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Neuvoprerana Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuvoprerana Foundation's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Neuvoprerana Foundation
Recent Activity within the Organization
  • Annual General Meeting

    Neuvoprerana Foundation last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Neuvoprerana Foundation has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    The activity Nilesh Pandit Mahajan was appointed as a Director was appointed as a Director on 15 Sep 2020 & has been associated with this company since 5 years 5 months . was completed.

  • Director Appointment

    Pandit Punjaram Mahajan was appointed as a Director was appointed as a Director on 15 Sep 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.

  • Director Appointment

    Sanjana Tushar Mahajan was appointed as a Director was appointed as a Director on 15 Sep 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.

  • Director Appointment

    Tushar Pandit Mahajan was appointed as a Director was appointed as a Director on 15 Sep 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Neuvoprerana Foundation?

The CIN of Neuvoprerana Foundation is U85100MH2020NPL346072.

Where is Neuvoprerana Foundation headquartered?

Neuvoprerana Foundation is headquartered at Fl03 Nishigandh Apt Satpur, Nashik, Maharashtra, 422007.

When was Neuvoprerana Foundation incorporated?

Neuvoprerana Foundation was incorporated on 15 September 2020.

Who are the current directors of Neuvoprerana Foundation?

The current directors of Neuvoprerana Foundation are

What is the primary industry of Neuvoprerana Foundation?

The primary industry of Neuvoprerana Foundation is Healthcare.

Is Neuvoprerana Foundation a listed company?

Neuvoprerana Foundation is unlisted.

What is the capital structure of Neuvoprerana Foundation?

The authorized capital of Neuvoprerana Foundation is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available